Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in mice.
about
Identification of inhibitors of PvdQ, an enzyme involved in the synthesis of the siderophore pyoverdine.Lipidomic analysis links mycobactin synthase K to iron uptake and virulence in M. tuberculosisSynthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactamsImproved Synthesis of Biotinol-5'-AMP: Implications for Antibacterial Discovery.Breaking a pathogen's iron will: Inhibiting siderophore production as an antimicrobial strategyDesigned Small-Molecule Inhibitors of the Anthranilyl-CoA Synthetase PqsA Block Quinolone Biosynthesis in Pseudomonas aeruginosaSynthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosisInvestigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis.Synthesis and pharmacological evaluation of nucleoside prodrugs designed to target siderophore biosynthesis in Mycobacterium tuberculosis.2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosis.Iron in intracellular infection: to provide or to deprive?Biosynthesis of mycobacterial lipids by polyketide synthases and beyond.Microbial siderophore-based iron assimilation and therapeutic applications.Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.Post-translational Acetylation of MbtA Modulates Mycobacterial Siderophore Biosynthesis.Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes.2016 EMBO Chemical Biology Conference.Conformationally Constrained Cinnolinone Nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis.
P2860
Q27683773-B6E6F14C-11E8-4FB1-BB97-AA3A3513C4ACQ28545076-7E61940C-1EA5-48B2-8926-E13A48BBEF06Q34229876-6AA7DE90-1F23-4481-9784-0141D2BBBE6DQ35086745-1866E80B-B780-4C20-BCF1-0002C875049EQ35688927-D4F0B9BD-FB9C-4AC8-A4B5-8F2F0BB9C98FQ36141081-C1ABEB05-D06E-42A1-9195-14326401EEDBQ36341699-D7C9F733-9D50-4D31-8C0B-92AAEF6DBB05Q36358981-DEC30AC0-C8A1-4F7B-8B13-035BE88B3B9CQ36627051-5EF4FFAB-C1E2-4C49-8E8C-EF53761E1C5BQ37022540-8C637FA9-2CE7-4399-AE6D-44B4C092DE9BQ37376232-3AC6DE2F-C114-42CC-ABF3-08B6446C8AF2Q38195645-6E9AE1B6-BE43-4A44-826D-AD5D9A2478F6Q38825854-D9BB1A68-D8BD-4B4A-A27D-9C04B778C898Q39003164-5BCDC15C-5000-40BE-BAC2-216EEDF00D20Q40561516-92C3B275-AD6D-4E0A-A131-5F1A75C68EBEQ42718330-6BBA2A7D-C96E-484C-AE95-4946F5EAF6C2Q48214971-5D38A13C-0BD7-49E6-A744-D084B6B52B15Q53072956-2C5C2FFB-BF6C-472F-8B5A-C28D4F44C247
P2860
Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic and in vivo ef ...... inhibitor salicyl-AMS in mice.
@en
Pharmacokinetic and in vivo ef ...... inhibitor salicyl-AMS in mice.
@nl
type
label
Pharmacokinetic and in vivo ef ...... inhibitor salicyl-AMS in mice.
@en
Pharmacokinetic and in vivo ef ...... inhibitor salicyl-AMS in mice.
@nl
prefLabel
Pharmacokinetic and in vivo ef ...... inhibitor salicyl-AMS in mice.
@en
Pharmacokinetic and in vivo ef ...... inhibitor salicyl-AMS in mice.
@nl
P2093
P2860
P50
P356
P1476
Pharmacokinetic and in vivo ef ...... inhibitor salicyl-AMS in mice
@en
P2093
Derek S Tan
Haidan Guo
John Adamson
Justin S Cisar
Luis E N Quadri
Shichun Lun
Sivagami Sundaram Chavadi
William R Bishai
P2860
P304
P356
10.1128/AAC.00918-13
P407
P577
2013-07-15T00:00:00Z